{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:19:18Z","timestamp":1787948358445,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"DOI":"10.7759\/cureus.115368","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:53:11Z","timestamp":1787946791000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation of Ankle-Brachial Index With NT-proBNP and Left Ventricular Ejection Fraction in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Apoorav","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhransu","family":"Patro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj U","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti Prakash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v14.i3.108099","article-title":"Unmasking the silent epidemic: mortality trends in diabetic nephropathy","volume":"14","author":"Alvarez M","year":"2025","unstructured":"Alvarez M. Unmasking the silent epidemic: mortality trends in diabetic nephropathy. World J Nephrol. 2025, 14:108099. 10.5527\/wjn.v14.i3.108099","journal-title":"World J Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_377_23","article-title":"SGLT2 inhibitors: paradigm shift from diabetes care to metabolic care \u2014 an Indian perspective","volume":"28","author":"Kumar KMP","year":"2024","unstructured":"Kumar KMP, Unnikrishnan AG, Jariwala P, et al.. SGLT2 inhibitors: paradigm shift from diabetes care to metabolic care \u2014 an Indian perspective. Indian J Endocrinol Metab. 2024, 28:11-18. 10.4103\/ijem.ijem_377_23","journal-title":"Indian J Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/nu18121973","article-title":"Narrative review: sugar and rice and the diabetes epidemic in India-a historical context","volume":"18","author":"Athinarayanan SJ","year":"2026","unstructured":"Athinarayanan SJ, Mascarenhas DD, Rajagopalan B, Fox JW, Lanaspa MA, Johnson RJ. Narrative review: sugar and rice and the diabetes epidemic in India-a historical context. Nutrients. 2026, 18:1973. 10.3390\/nu18121973","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.109935","article-title":"Advanced glycation end products and genetic polymorphism in the pathogenesis of microvascular complications in type 2 diabetes mellitus: a narrative review","volume":"18","author":"Sarangi R","year":"2026","unstructured":"Sarangi R, Singh S, Sahoo JP, Satpathy A. Advanced glycation end products and genetic polymorphism in the pathogenesis of microvascular complications in type 2 diabetes mellitus: a narrative review. Cureus. 2026, 18:109935. 10.7759\/cureus.109935","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.040640","article-title":"Advanced glycation end-product carboxymethyl-lysine and incident heart failure and atrial fibrillation in older adults","volume":"14","author":"Bene-Alhasan Y","year":"2025","unstructured":"Bene-Alhasan Y, Bartz TM, Djouss\u00e9 L, et al.. Advanced glycation end-product carboxymethyl-lysine and incident heart failure and atrial fibrillation in older adults. J Am Heart Assoc. 2025, 14:040640. 10.1161\/JAHA.124.040640","journal-title":"J Am Heart Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05821-3","article-title":"Advanced glycation end-products, cardiac function and heart failure in the general population: the Rotterdam study","volume":"66","author":"Arshi B","year":"2023","unstructured":"Arshi B, Chen J, Ikram MA, Zillikens MC, Kavousi M. Advanced glycation end-products, cardiac function and heart failure in the general population: the Rotterdam study. Diabetologia. 2023, 66:472-481. 10.1007\/s00125-022-05821-3","journal-title":"Diabetologia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1637252","article-title":"The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies","volume":"12","author":"Li ZH","year":"2025","unstructured":"Li ZH, Wang XY, Luo Q. The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies. Front Cardiovasc Med. 2025, 12:1637252. 10.3389\/fcvm.2025.1637252","journal-title":"Front Cardiovasc Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.089656","article-title":"Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure","volume":"93","author":"Raphael C","year":"2007","unstructured":"Raphael C, Briscoe C, Davies J, et al.. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007, 93:476-482. 10.1136\/hrt.2006.089656","journal-title":"Heart"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-2200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/biom14030309","article-title":"Beyond natriuretic peptides: unveiling the power of emerging biomarkers in heart failure","volume":"14","author":"Licordari R","year":"2024","unstructured":"Licordari R, Correale M, Bonanno S, et al.. Beyond natriuretic peptides: unveiling the power of emerging biomarkers in heart failure. Biomolecules. 2024, 14:309. 10.3390\/biom14030309","journal-title":"Biomolecules"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac125","article-title":"Natriuretic peptide pathways in heart failure: further therapeutic possibilities","volume":"118","author":"Sangaralingham SJ","year":"2023","unstructured":"Sangaralingham SJ, Kuhn M, Cannone V, Chen HH, Burnett JC. Natriuretic peptide pathways in heart failure: further therapeutic possibilities. Cardiovasc Res. 2023, 118:3416-3433. 10.1093\/cvr\/cvac125","journal-title":"Cardiovasc Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14019","article-title":"Higher BNP\/NT-pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta-analysis","volume":"9","author":"Hendricks S","year":"2022","unstructured":"Hendricks S, Dykun I, Balcer B, Totzeck M, Rassaf T, Mahabadi AA. Higher BNP\/NT-pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta-analysis. ESC Heart Fail. 2022, 9:3198-3209. 10.1002\/ehf2.14019","journal-title":"ESC Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-020-00249-2","article-title":"N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people","volume":"43","author":"Muscari A","year":"2021","unstructured":"Muscari A, Bianchi G, Forti P, et al.. N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people. Geroscience. 2021, 43:845-857. 10.1007\/s11357-020-00249-2","journal-title":"Geroscience"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield MM","year":"2002","unstructured":"Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr.. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002, 40:976-982. 10.1016\/s0735-1097(02)02059-4","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2174\/1568026611313020002","article-title":"NTproBNP: an important biomarker in cardiac diseases","volume":"13","author":"Panagopoulou V","year":"2013","unstructured":"Panagopoulou V, Deftereos S, Kossyvakis C, et al.. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem. 2013, 13:82-94. 10.2174\/1568026611313020002","journal-title":"Curr Top Med Chem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd11070225","article-title":"The role of NT-proBNP levels in the diagnosis and treatment of heart failure with preserved ejection fraction-it is not always a hide-and-seek game","volume":"11","author":"Chrysohoou C","year":"2024","unstructured":"Chrysohoou C, Konstantinou K, Tsioufis K. The role of NT-proBNP levels in the diagnosis and treatment of heart failure with preserved ejection fraction-it is not always a hide-and-seek game. J Cardiovasc Dev Dis. 2024, 11:225. 10.3390\/jcdd11070225","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the international collaborative of NT-proBNP study","volume":"27","author":"Januzzi JL","year":"2006","unstructured":"Januzzi JL, van Kimmenade R, Lainchbury J, et al.. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the international collaborative of NT-proBNP study. Eur Heart J. 2006, 27:330-337. 10.1093\/eurheartj\/ehi631","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.94162","article-title":"N\u2011terminal pro-B-type natriuretic peptide (NT-proBNP) as a biomarker in heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF): the way forward in the age of proteomics","volume":"17","author":"Kanyal S","year":"2025","unstructured":"Kanyal S, Das A, Bashir AMD, et al.. N\u2011terminal pro-B-type natriuretic peptide (NT-proBNP) as a biomarker in heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF): the way forward in the age of proteomics. Cureus. 2025, 17:94162. 10.7759\/cureus.94162","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011366","article-title":"Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea","volume":"17","author":"Kosyakovsky LB","year":"2024","unstructured":"Kosyakovsky LB, Liu EE, Wang JK, et al.. Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea. Circ Heart Fail. 2024, 17:011366. 10.1161\/CIRCHEARTFAILURE.123.011366","journal-title":"Circ Heart Fail"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.03.057","article-title":"Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION)","volume":"108","author":"Jones WS","year":"2011","unstructured":"Jones WS, Clare R, Ellis SJ, et al.. Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). Am J Cardiol. 2011, 108:380-384. 10.1016\/j.amjcard.2011.03.057","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22716","article-title":"Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction","volume":"40","author":"Sandesara PB","year":"2017","unstructured":"Sandesara PB, Hammadah M, Samman-Tahhan A, Kelli HM, O'Neal WT. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction. Clin Cardiol. 2017, 40:692-696. 10.1002\/clc.22716","journal-title":"Clin Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.02.033","article-title":"Abnormal ankle-brachial index (ABI) predicts primary and secondary cardiovascular risk and cancer mortality","volume":"77","author":"Vison\u00e0 A","year":"2020","unstructured":"Vison\u00e0 A, De Paoli A, Fedeli U, et al.. Abnormal ankle-brachial index (ABI) predicts primary and secondary cardiovascular risk and cancer mortality. Eur J Intern Med. 2020, 77:79-85. 10.1016\/j.ejim.2020.02.033","journal-title":"Eur J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02668-9","article-title":"Prevalence and risk factors for vascular calcification based on the ankle-brachial index in the general population: a cross-sectional study","volume":"22","author":"Chen S","year":"2022","unstructured":"Chen S, Li N, Gao Y, Jiang H, Shen Y. Prevalence and risk factors for vascular calcification based on the ankle-brachial index in the general population: a cross-sectional study. BMC Cardiovasc Disord. 2022, 22:227. 10.1186\/s12872-022-02668-9","journal-title":"BMC Cardiovasc Disord"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22475","article-title":"Postexercise ankle-brachial index testing to diagnose peripheral artery disease","volume":"325","author":"Mah\u00e9 G","year":"2021","unstructured":"Mah\u00e9 G, Lan\u00e9elle D, Le Faucheur A. Postexercise ankle-brachial index testing to diagnose peripheral artery disease. JAMA. 2021, 325:89. 10.1001\/jama.2020.22475","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-016-2223-y","article-title":"Kuppuswamy's socio-economic status scale: a revision of occupation and income criteria for 2016","volume":"84","author":"Khairnar MR","year":"2017","unstructured":"Khairnar MR, Wadgave U, Shimpi PV. Kuppuswamy's socio-economic status scale: a revision of occupation and income criteria for 2016. Indian J Pediatr. 2017, 84:3-6. 10.1007\/s12098-016-2223-y","journal-title":"Indian J Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06870909","article-title":"Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size","volume":"5","author":"Michels WM","year":"2010","unstructured":"Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010, 5:1003-1009. 10.2215\/CJN.06870909","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","unstructured":"R. The R Project for Statistical Computing. (2026). Accessed: July 25, 2026: http:\/\/www.r-project.org\/."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.11.001","article-title":"Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: a multicenter observational study","volume":"61","author":"\u00d6zlek B","year":"2019","unstructured":"\u00d6zlek B, \u00d6zlek E, A\u011fu\u015f HZ, et al.. Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: a multicenter observational study. Eur J Intern Med. 2019, 61:88-95. 10.1016\/j.ejim.2018.11.001","journal-title":"Eur J Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2017.04.007","article-title":"Biomarker profiles of acute heart failure patients with a mid-range ejection fraction","volume":"5","author":"Tromp J","year":"2017","unstructured":"Tromp J, Khan MAF, Mentz RJ, et al.. Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC Heart Fail. 2017, 5:507-517. 10.1016\/j.jchf.2017.04.007","journal-title":"JACC Heart Fail"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.010395","article-title":"Left ventricular gene expression in heart failure with preserved ejection fraction-profibrotic and proinflammatory pathways and genes","volume":"16","author":"Ye B","year":"2023","unstructured":"Ye B, Bradshaw AD, Abrahante JE, et al.. Left ventricular gene expression in heart failure with preserved ejection fraction-profibrotic and proinflammatory pathways and genes. Circ Heart Fail. 2023, 16:e010395. 10.1161\/CIRCHEARTFAILURE.123.010395","journal-title":"Circ Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/526305-correlation-of-ankle-brachial-index-with-nt-probnp-and-left-ventricular-ejection-fraction-in-patients-with-type-2-diabetes-mellitus-and-heart-failure-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:53:12Z","timestamp":1787946792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/526305-correlation-of-ankle-brachial-index-with-nt-probnp-and-left-ventricular-ejection-fraction-in-patients-with-type-2-diabetes-mellitus-and-heart-failure-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.115368","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}